Artificial Intelligence Algorithms for the Detection of Pathologies Related to Lung Cancer through Image Analysis using Convolutional Neural Networks and Data Augmentation: a systematic mapping of…

A systematic literature mapping published on arXiv reviewed 96 articles from 2015 onward on AI and deep learning for lung cancer detection in radiology, finding convolutional neural networks with transfer learning and data augmentation can deliver high sensitivity and specificity for early diagnosis. The review, which searched PubMed, IEEEXPLORE, Scopus and Web of Science, identified limitations including lack of standardized data, model explainability, patient privacy, and ethical and social implications. The authors concluded that further research and regulation are required to ensure the quality and reliability of AI in clinical practice.

arXiv:2609.10652v1 Announce Type: new Abstract: Lung cancer is one of the leading causes of death worldwide, and its early diagnosis is crucial to improving patients prognosis and quality of life. However, the process of interpreting medical images for the detection of lung cancer is complex and requires trained experts. In this context, artificial intelligence AI and deep learning DL emerge as potential tools to automate and optimize image analysis. The objective of this work is to review the most recent and relevant applications of AI and DL in the field of radiology for the detection of lung cancer. To this end, an exhaustive search was carried out in scientific databases such as PubMed,IEEEXPLORE, Scopus and Web of Science, and 96 articles published from 2015 to the present addressing the use of AI and DL in biomedical engineering were selected. Emphasis is placed on the use of convolutional neural networks CNN with transfer learning and Data Augmentation as promising techniques to improve the accuracy and efficiency of the image interpretation process. The results show that the use of AI and DL can offer an effective alternative for the early diagnosis of lung cancer, with high sensitivity and specificity. However, current limitations and challenges that must be addressed to guarantee its responsible and safe application in clinical practice are also identified, such as the lack of standardized data, the ex plainability of the models, patient privacy, and the ethical and social implications. It is concluded that the use of AI and DL can have a positive impact on the care of patients with lung cancer, but further research and regulation are required to ensure its quality and reliability.